Safety Profile Overview
Prodrug stimulant for ADHD and binge eating disorder. Designed to reduce abuse potential through its prodrug mechanism.
Generic Name
lisdexamfetamine
Brand Names
Vyvanse
Therapeutic Class
CNS Stimulant
Manufacturer
Takeda
What Pharma Signal Tracks for Vyvanse
- Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Vyvanse, including serious outcomes, hospitalizations, and deaths.
- FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Vyvanse products.
- Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
- Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
- Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
- Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.
Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.
Get Vyvanse Safety Data via API
One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Vyvanse.
curl "https://api.pharma-signal.com/drug/safety/vyvanse" \ -H "X-API-Key: your_key" # Returns risk score, adverse event counts, # serious/death rates, recalls, and signals
Related Safety Intelligence
Pharma Signal provides comparative analysis across therapeutic classes. Compare Vyvanse against other CNS Stimulant drugs, or explore the full manufacturer portfolio for Takeda.
- Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
- Therapeutic class benchmarking — See how Vyvanse ranks within CNS Stimulant on serious event rates.
- Company portfolio risk — View all drugs from Takeda with aggregate risk exposure.
- AI analyst briefs — Get a natural-language safety assessment combining all data sources.